FYCO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.626032641866E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.22699653057634E-11 |
Normal-vs-Stage2 |
3.66450000000018E-05 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
6.265800E-01 |
Stage1-vs-Stage3 |
3.0382000000273E-06 |
Stage1-vs-Stage4 |
7.71700000000708E-05 |
Stage2-vs-Stage3 |
1.190560E-01 |
Stage2-vs-Stage4 |
1.085040E-01 |
Stage3-vs-Stage4 |
8.222600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62525548574877E-12 |
Normal-vs-AfricanAmerican |
1.6498199999937E-05 |
Normal-vs-Asian |
1.001660E-02 |
Caucasian-vs-AfricanAmerican |
1.677610E-01 |
Caucasian-vs-Asian |
5.417600E-01 |
AfricanAmerican-vs-Asian |
9.642400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62703184258817E-12 |
Normal-vs-Female |
1.63402624764331E-12 |
Male-vs-Female |
6.154400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.2697000000036E-05 |
Normal-vs-Age(41-60Yrs) |
5.56332757639666E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
6.0185967321047E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.844200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.832400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.415900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.788300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.676400E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.672100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.151820E-02 |
Normal-vs-Grade 2 |
4.84834394853806E-13 |
Normal-vs-Grade 3 |
2.77555756156289E-15 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
2.602600E-01 |
Grade 1-vs-Grade 3 |
1.214450E-01 |
Grade 1-vs-Grade 4 |
5.942200E-03 |
Grade 2-vs-Grade 3 |
1.983570E-01 |
Grade 2-vs-Grade 4 |
6.215300E-03 |
Grade 3-vs-Grade 4 |
1.234250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62447832963153E-12 |
Normal-vs-ccB subtype |
5.73570000050871E-07 |
ccA subtype-vs-ccB subtype |
2.561000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.84696702376641E-12 |
Normal-vs-N1 |
3.42859999946654E-07 |
N0-vs-N1 |
3.885000E-01 |
|
|